ASH 2017: Brentuximab Vedotin + Doxorubicin, Vinblastine, Dacarbazine Proves Superior to ABVD in Previously Untreated Stage 3 or 4 Hodgkin’s Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.